Science Explorer Back to mapMap
Discussion
Researcher · Debiopharm (Switzerland) · Switzerland

Anna Pokorska-Bocci

Anna Pokorska-Bocci publishes mostly in Molecular Biology, Cancer Research and Oncology, on topics such as Fibroblast Growth Factor Research, Cancer, Hypoxia, and Metabolism and Cholangiocarcinoma and Gallbladder Cancer Studies.

ORCID 0009-0004-6356-875X OpenAlex
World rank
#2,090,959
of 7,710,434 ranked researchers
Rank in Switzerland
#33,029
of 80,918
Works
46
Citations
432
Citations per work
9.4
h-index
9
i10-index 9Top 82% in Molecular Biology
Anna Pokorska-Bocci

What does Anna Pokorska-Bocci research?

Anna Pokorska-Bocci's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (41%).

Life Sciences: 24 works · 52.4% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 52.4% of their workMolecular Biology: 18 works · 38.1% of their workCancer Research: 7 works · 14.3% of their workHealth Sciences: 19 works · 41.2% of their workMedicine: 19 works · 41.2% of their workOncology: 6 works · 12.7% of their workPulmonary and Respiratory Medicine: 4 works · 9.5% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 9.5% of their workSurgery: 4 works · 9.5% of their workEverything else: 3 works · 6.4% of their workTHEIR WORKAnnaPokorska-Bocci46works
Life Sciences52%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2452.4%
    1. Medicine1941.2%
  3. Everything else36.4%
  1. 1Molecular Biology38% of their works
  2. 2Cancer Research14% of their works
  3. 3Oncology13% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Pulmonary and Respiratory Medicine10% of their works
  6. 6Surgery10% of their works

Research topics

Which keywords describe Anna Pokorska-Bocci's research?

The keywords of their largest research topics: Cancer, FGF21, Fibroblast Growth Factor, Tumor Hypoxia, HIF-1, Warburg Effect, Biliary Tract Cancer and Cholangiocarcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer162 topics
  2. FGF21141 topic
  3. Fibroblast Growth Factor141 topic
  4. Tumor Hypoxia102 topics
  5. HIF-171 topic
  6. Warburg Effect71 topic
  7. Biliary Tract Cancer41 topic
  8. Cholangiocarcinoma41 topic
  9. Carbonic Anhydrases31 topic
  10. Inhibitors31 topic
  11. Medical Imaging31 topic
  12. Pulmonary Alveolar Microlithiasis31 topic
  13. Pulmonary Sclerosing Hemangioma31 topic
  14. Radiomics31 topic
  15. Cancer Genomics21 topic
  16. Krüppel-like Factors21 topic
  17. Mutational Signatures21 topic
  18. Transcriptional Regulation21 topic

Where does Anna Pokorska-Bocci work?

Anna Pokorska-Bocci's main affiliation in the publication record is Debiopharm (Switzerland), Switzerland.

How many publications and citations does Anna Pokorska-Bocci have?

OpenAlex counts 46 works and 432 citations for Anna Pokorska-Bocci, an h-index of 9, ranking #2,090,959 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anna Pokorska-Bocci. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.